New study aims to help thousands better manage type 2 diabetes
NCT ID NCT06251323
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 34 times
Summary
This large study tests a new way of delivering diabetes care called iPATH, which uses a team of providers and technology to help patients better control their blood sugar. Researchers will enroll about 120,000 adults with type 2 diabetes at 16 community health centers across the U.S. The goal is to see if this approach can reduce the number of patients with dangerously high blood sugar levels.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Board of Trustees of the Leland Stanford Junior University
RECRUITINGStanford, California, 94305, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Impactivo, LLC.
RECRUITINGSan Juan, Puerto Rico, 00907, Puerto Rico
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
President and Fellows of Harvard College, T.H. Chan School
RECRUITINGBoston, Massachusetts, 02115, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Ohio State University
RECRUITINGColumbus, Ohio, 43210, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
iPATH implementation approach (team-based, technology-enabled care model)
What this could lead to
If successful, this could provide a scalable way to improve diabetes management in underserved communities, reducing complications from poorly controlled blood sugar.
What could go wrong
This is an implementation study, not a drug trial, so benefits depend on how well clinics adopt the new approach. Results may vary across different health centers and patient populations.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.